NCT02290717: Fractional Laser in Combination With UVB Therapy in Vitiligo Patients |
|
|
| Withdrawn | N/A | 0 | Europe | Fractional CO2 laser, NB-UVB therapy, Fluticasone Propionate Cream 0.05% | Netherlands Institute for Pigment Disorders | Vitiligo | 11/15 | 11/15 | | |
ChiCTR2000031143: clinical trial of a long-term intermittent treatment of 0.05% fluticasone propionate cream to prevent recurrence of vitiligo |
|
|
| Recruiting | N/A | 192 | | Fluticasone propionate cream was used as a placebo for topical treatment once every Saturday and Sunday, and the duration of administration for 12 months. ;Topical rubbing with 0.05% fluticasone propionate cream (15g / stick, Aramco Pharmaceutical Co., Ltd., the same below), topical application once every Saturday and Sunday, maintaining medication for 3 months. ;Topical rubbing with 0.05% fluticasone propionate cream, topical application once every Saturday and Sunday, maintaining medication for 6 months. ;Topical rubbing with 0.05% fluticasone propionate cream, topical application once every Saturday and Sunday, maintaining medication for 12 months. | Dermatology Hospital, Southern Medical University; The Sixth Affiliated Hospital of Sun Yat-Sen University, Dermatology Hospital, Southern Medical University | vitiligo | | | | |
| Recruiting | N/A | 90 | | Wet-wrap treatment with fluticasone propionate cream 0.05% ;Wet-wrap treatment with hydrocortisone butyrate 0.1% cream ;0.05% Fluticasone propionate cream for external application | Dermatology Hospital of Southern Medical University; Dermatology Hospital of Southern Medical University, Bright Future Pharmaceutical | Atopic dermatitis | | | | |
